文献速递肝病消化道肿瘤与早癌

整合素αV-YAP-CTGF轴在肝窦内皮细胞中促进充血性肝病纤维化及门脉高压和肝癌发生

Activation of the Integrin αV-YAP-CTGF Axis in Liver Sinusoidal Endothelial Cells Promotes Liver Fibrogenesis, Leading to Portal Hypertension and Liver Carcinogenesis in Congestive Hepatopathy.
PubMed 文献 · Gastroenterology · 2026-02-27

本研究通过小鼠部分下腔静脉结扎(pIVCL)模型及人Fontan相关肝病样本,结合单细胞RNA测序和空间转录组学,发现肝窦内皮细胞(LSEC)中整合素αV-YAP-CTGF轴激活促进充血性肝病纤维化,进而导致门脉高压和肝癌发生;抑制该轴可减轻纤维化和门脉高压。

要点

  • LSEC中CTGF敲除可改善充血性肝病纤维化和门脉高压并抑制肝肿瘤发生。
  • 抑制整合素αV可减轻充血性肝病纤维化和门脉高压,降低CTGF、COL4和COL1表达。
  • LSEC来源CTGF上调肝星状细胞COL1和COL4表达,促进纤维化。

核心结论

  • LSEC中CTGF诱导可能在上游促进充血性肝病纤维化,整合素αV-YAP-CTGF轴是潜在治疗靶点。

研究设计与样本

  • 小鼠行部分下腔静脉结扎(pIVCL)诱导肝充血,并进行单细胞RNA测序(scRNA-seq)。
  • 细胞接受静水压刺激,人Fontan相关肝病肝脏行scRNA-seq和空间转录组学。

主要发现

  • pIVCL后中央周围LSEC中整合素信号通路和YAP激活,CTGF为上调最显著基因。
  • 静水压通过整合素αV激活YAP,上调LSEC中CTGF和IV型胶原(COL4)表达。
  • LSEC来源CTGF上调肝星状细胞I型胶原(COL1)和COL4表达。
  • 内皮细胞CTGF敲除改善CH诱导的肝纤维化和门脉高压,并抑制肝肿瘤发生。
  • 抑制整合素αV减轻CH诱导的肝纤维化和门脉高压,降低CTGF、COL4和COL1表达。

临床怎么用

  • 整合素αV-YAP-CTGF轴可作为充血性肝病潜在治疗靶点,CTGF和整合素αV抑制可能减轻纤维化和门脉高压。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Chronic liver congestion progresses to liver fibrosis, eventually leading to cirrhosis and cancer. This study aimed to elucidate the mechanism of congestive hepatopathy (CH), focusing on liver sinusoidal endothelial cells (LSECs). METHODS: Partial inferior vena cava ligation (pIVCL) was performed to induce hepatic congestion in mice. Single-cell RNA sequencing (scRNA-seq) was conducted on murine livers after pIVCL. Cells underwent hydrostatic pressure stimulation. scRNA-seq and spatial transcriptomics were performed on human livers from patients with Fontan-associated liver disease. RESULTS: The scRNA-seq analysis showed that the integrin signaling pathway and yes-associated protein (YAP) were activated in pericentral LSECs after pIVCL. The most upregulated gene in pericentral LSECs was connective tissue growth factor (CTGF). Hydrostatic pressure activated YAP through integrin αV, leading to the upregulation of CTGF and type IV collagen (COL4) expression in LSECs. LSEC-derived CTGF upregulated the type I collagen (COL1) and COL4 expression in hepatic stellate cells. CTGF knockout in endothelial cells ameliorated CH-induced liver fibrosis and portal hypertension and even suppressed liver tumorigenesis. Integrin αV inhibition alleviated CH-induced liver fibrosis and portal hypertension with the decreased expression of CTGF, COL4, and COL1. scRNA-seq and spatial transcriptomics of clinical Fontan-associated liver disease samples revealed YAP activation and CTGF upregulation in pericentral LSECs, potentially leading to increased COL4 expression in LSECs and increased COL1 expression in hepatic stellate cells as fibrosis progressed. CONCLUSIONS: CTGF induction in LSECs may play an upstream role in the fibrogenesis of CH. The integrin αV-YAP-CTGF axis in LSECs could be a potential therapeutic target for CH.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Kato S, Hikita H, Tsukamoto O, et al. Activation of the Integrin αV-YAP-CTGF Axis in Liver Sinusoidal Endothelial Cells Promotes Liver Fibrogenesis, Leading to Portal Hypertension and Liver Carcinogenesis in Congestive Hepatopathy. Gastroenterology. 2026. PMID: 41758081. doi:10.1053/j.gastro.2025.11.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。